Cargando…
Metformin as an adjuvant treatment for cancer: a systematic review and meta-analysis
BACKGROUND: Metformin use has been associated with a reduced risk of developing cancer and an improvement in overall cancer survival rates in meta-analyses, but, to date, evidence to support the use of metformin as an adjuvant therapy in individual cancer types has not been presented. PATIENTS AND M...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5178140/ https://www.ncbi.nlm.nih.gov/pubmed/27681864 http://dx.doi.org/10.1093/annonc/mdw410 |